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Pigs are susceptible to infection with the classical bovine spongiform encephalopathy (C‑BSE) agent 
following experimental inoculation, and  PrPSc accumulation was detected in porcine tissues after the 
inoculation of certain scrapie and chronic wasting disease isolates. However, a robust transmission 
barrier has been described in this species and, although they were exposed to C‑BSE agent in 
many European countries, no cases of natural transmissible spongiform encephalopathies (TSE) 
infections have been reported in pigs. Transmission of atypical scrapie to bovinized mice resulted in 
the emergence of C‑BSE prions. Here, we conducted a study to determine if pigs are susceptible to 
atypical scrapie. To this end, 12, 8–9‑month‑old minipigs were intracerebrally inoculated with two 
atypical scrapie sources. Animals were euthanized between 22‑ and 72‑months post inoculation 
without clinical signs of TSE. All pigs tested negative for  PrPSc accumulation by enzyme immunoassay, 
immunohistochemistry, western blotting and bioassay in porcine PrP mice. Surprisingly, in vitro 
protein misfolding cyclic amplification demonstrated the presence of C‑BSE prions in different brain 
areas from seven pigs inoculated with both atypical scrapie isolates. Our results suggest that pigs 
exposed to atypical scrapie prions could become a reservoir for C‑BSE and corroborate that C‑BSE 
prions emerge during interspecies passage of atypical scrapie.
Transmissible spongiform encephalopathies (TSE) are neurodegenerative diseases that affect humans and various 
animal species and include scrapie (classical and atypical) in sheep and goats, chronic wasting disease (CWD) 
in cervids, bovine spongiform encephalopathy (BSE) in cattle and variant Creutzfeldt-Jakob disease (vCJD) in 
humans. They are characterized by the presence of a misfolded and neurotoxic protein  (PrPSc), an abnormal 
isoform of a glycoprotein encoded by the host called cellular PrP  (PrPC). Both proteins share the same amino acid 
sequence, but differ in their secondary  structure1. The natural transmission of TSE in animals usually involves 
an oral exposure to the  agent2.
In the pigs, to date, no field cases of TSE of natural origin have been described, despite the fact that epide-
miological studies performed in the United Kingdom showed that they were exposed to contaminated feed 
containing ruminant meat and bone  meal3,4. However, pigs are susceptible to parenteral experimental infection 
with classical BSE (C-BSE), and sheep BSE (SBSE)  agents4–7. We previously demonstrated that pigs are efficiently 
infected with the SBSE agent, which leads to a 100% attack rate when inoculated intracerebrally in pigs and a 
widespread distribution of  PrPSc, which is present in a wide variety of peripheral tissues and blood components 
from these  animals7,8. However, SBSE has been suggested to be more pathogenic than cattle C-BSE9. Konold 
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et al. reported incomplete attack rates after intracranial inoculation of pigs with C-BSE6 and pigs are apparently 
resistant to C-BSE after oral  challenge4. The transmissibility of chronic wasting disease (CWD) to the pig has also 
been demonstrated, and  PrPSc accumulation can be detected in these animals by RT-QuIC as soon as 6 months 
after inoculation. However, pigs accumulated low levels of  PrPCWD and subsequent bioassays in PrP porcine 
transgenic mice demonstrated a strong transmission barrier to CWD prion propagation in  pigs10.
PrPSc deposition and infectivity have been also reported in pigs inoculated with an isolate of classical scrapie, 
but these animals did not develop clinical signs of TSE and  PrPSc could only be detected by conventional tech-
niques in aged  animals11. Propagation of other classical scrapie isolates in piglets or transgenic mice overexpress-
ing porcine  PrPC (PoPrP-Tg001 mice, hereafter referred to as tgPo) has been  unsuccessful12,13. Surprisingly, it 
was shown that one atypical scrapie isolate was able to propagate in tgPo mice.
Although a strong transmission barrier was observed, this atypical scrapie isolate experimented a drastic 
molecular shift, acquiring similar biochemical properties to those of SBSE when transmitted to tgPo  mice13. 
However, the same atypical scrapie isolate was not able to reproduce the infection when inoculated again in tgPo 
mice in a posterior  study14 leaving the question of whether pigs are susceptible to atypical scrapie still open. The 
emergence of C-BSE prions from atypical scrapie isolates was further demonstrated both in vivo and in vitro. 
Transmission of atypical scrapie isolates from 5 different European countries to mice expressing the bovine prion 
protein resulted in the propagation of C-BSE. Serial in vitro amplification of these atypical scrapie isolates by 
protein misfolding cyclic amplification (PMCA) in bovine and ovine PrP substrates demonstrated that C-BSE 
emerges as the dominant strain in both PrP  substrates15.
In this study, we tested the susceptibility of pigs to two atypical scrapie isolates by intracerebral inoculation. 
Challenged animals did not show clinical signs compatible with a TSE, and collected tissues tested negative for 
 PrPSc accumulation by conventional techniques. In addition, we did not find infectivity in brain tissues from 
atypical scrapie-inoculated pigs by mouse bioassay in tgPo mice. Surprisingly, PMCA reactions seeded with brain 
material from seven of the pigs resulted positive for the propagation of C-BSE prions. Positive PMCA reactions 
were obtained from pigs inoculated with either of the original atypical isolates. These results corroborate that 
C-BSE can emerge during passage of atypical scrapie between different livestock species and that pigs could act 
as a reservoir for C-BSE.
Results
No  PrPSc accumulation is detected in brains from pigs inoculated with atypical scrapie. Atypi-
cal scrapie-inoculated pigs were monitored periodically by veterinary staff. None of the animals showed clinical 
signs compatible with a TSE. However, several pigs developed concomitant pathologies and were euthanized 
when their welfare was compromised. Other animals were electively euthanized to test the evolution of the 
disease (Table 1).
The evaluation of the brain sections stained with hematoxylin–eosin did not reveal any spongiform changes. 
None of the challenged pigs showed  PrPSc accumulation in the brain by enzyme immunoassay (EIA) (Table 2), 
immunohistochemistry or western blotting (not shown).
All pigs were also tested for infectivity in brain tissues by mouse bioassay. TgPo mice were selected as an 
appropriate model for the bioassay because this line overexpresses pig PrP (fourfold the level of expression in 
pig  brain13), therefore representing no transmission barrier for porcine prions. TgPo mice were euthanized after 
650 days post inoculation (dpi) without showing clinical signs compatible with a TSE. None of these mice were 
positive for  PrPSc accumulation in their brains. Details of the mouse bioassay are represented in Table 3.
C‑BSE prions emerge during the in vitro propagation of brain isolates from pigs challenged 
with atypical scrapie. In vitro propagation by PMCA demonstrated recently that C-BSE prions can be 
present in ovine atypical scrapie isolates. C-BSE can also emerge during the inter-species passage of atypical 
 scrapie15. To detect whether C-BSE emerged in the atypical scrapie-challenged pigs, brain material from these 
Table 1.  Inoculation of pigs with atypical scrapie isolates. a Pigs were euthanized without showing clinical 
signs of TSE.
ID Isolate Sex Months post-inoculationa Reasons for euthanasia
P-1217 PS152 Female 28 Elective
P-1216 PS152 Female 44 Elective
P-1213 PS152 Female 48 Stomach ulcer
P-1212 PS152 Female 50 Uterine infection
P-1215 PS152 Female 62 Elective
P-1214 PS152 Female 72 Elective
P-1226 TOA3 Female 22 Inner ear infection
P-1231 TOA3 Neutered male 35 Elective
P-1228 TOA3 Female 47 Uterine infection
P-1229 TOA3 Female 48 Uterine infection and intestinal haemorrhage
P-1227 TOA3 Female 62 Elective
P-1230 TOA3 Female 67 Uterine infection
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animals was subjected to PMCA using substrates from transgenic mice expressing bovine PrP (tgBov). This 
substrate was selected because it is the most permissive for C-BSE amplification, whereas several PMCA rounds 
are required to amplify C-BSE using tgPo brain as a  substrate14.
Interestingly,  PrPSc amplification was detected in reactions seeded with brain material from 7 pigs (Supple-
mentary table 1). Each brain area was tested in quadruplicate and positive reactions were confirmed by retesting 
the original sample in 12 PMCA replicates.
Table 2.  Enzyme immunoassay test results for atypical scrapie inoculated pigs. a EIA test was performed using 
a negative cut off value of 0.14 absorbance units.





































Atypical scrapie clinical sheep
Frontal cortex 2.878
Cerebellum 0.825
Sheep BSE inoculated pig
Frontal cortex 3.372
Cerebellum 3.374
Table 3.  Bioassay in tgPo mice. a Mice were inoculated with a 10% brain pool from each atypical scrapie-
challenged pig.
Brain  homogenatesa Attack rate Survival time, dpi
P-1212 0/5  > 650
P-1213 0/5  > 650
P-1214 0/5  > 650
P-1215 0/7  > 650
P-1216 0/5  > 650
P-1217 0/5  > 650
P-1226 0/6  > 650
P-1227 0/6  > 650
P-1228 0/5  > 650
P-1229 0/5  > 650
P-1230 0/5  > 650
P-1231 0/5  > 650
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PrPres western blot profile from positive PMCA reactions was characterized by a predominance of the di-
glycosylated band, non-glycosylated band at ~ 19 kDa and lack of detection with the 12B2 antibody (Fig. 1). These 
features are undistinguishable from C-BSE prions and PMCA reaction products seeded with C-BSE prions. No 
 PrPres was detected in unseeded PMCA reactions or those seeded with brain homogenate from a TSE negative 
sheep (Fig. 1).
Discussion
The outbreak of C-BSE was followed by the appearance of TSE in species that had never been diagnosed with 
prion diseases and the emergence in humans of  vCJD16–18. However, no natural prion disease has been described 
in pigs, even though they were exposed to C-BSE contaminated  feed12. Posterior experimental challenges in pigs 
and mice expressing porcine PrP have demonstrated that, although they are not completely resistant, pigs present 
a robust transmission barrier for C-BSE  prions4,14,19.
However, the possible transmission of a TSE to swine is a public health concern due to the wide use of pork 
as a source of human food, and the increasing use of pigs as tissue donors, being reported a case of vCJD in a 
human patient receiving a swine dura mater  graft20. Although pigs are apparently non-susceptible to C-BSE after 
oral  challenge4,5,21, infectivity has been detected in tissues from pigs orally inoculated with classical scrapie or 
 CWD10,11. In addition, these positive orally inoculated pigs are often subclinical, what could represent a public 
health concern, considering that these animals could reach the slaughterhouse without showing signs suggestive 
of prion disease.
In the present study, we evaluated the transmissibility of atypical scrapie to pigs. Pigs were euthanized between 
22- and 72-months post inoculation (mpi), and their tissues tested for  PrPSc accumulation and infectivity. We 
did not find evidence of transmission of atypical scrapie to any of the animals by EIA (Table 2), western blotting, 
or mouse bioassay (Table 3).  PrPSc accumulation can be detected in BSE-challenged pigs at 34  mpi4, and at 22 
mpi when inoculated with  SBSE7. Although scrapie or CWD-inoculated pigs do not show clinical signs,  PrPSc 
presence can be found in scrapie-challenged animals at 51  mpi11 and as early as 6 mpi in the case of  CWD10.
Our main goal was to test the ability of atypical scrapie/Nor98 strain to propagate in swine, given that mice 
expressing porcine PrP (PoPrP-Tg001/tgPo mice) showed to be susceptible to atypical scrapie inoculation. One 
atypical scrapie isolate adapted to this transgenic line, reaching a 100% attack rate and rapid incubation periods 
in serial  passages13, a similar adaptation to that observed with the C-BSE  agent19. However, when this atypical 
scrapie isolate was tested for propagation in tgPo mice again, together with other atypical scrapie isolates, no 
positive results were obtained, in vitro nor in vivo14. These results, together with the negative transmissions 
showed in the present study, reinforce the conclusion that porcine species is highly resistant to atypical scrapie. 
However, we only performed one passage in tgPo mice, and further passages in this line and/or PMCA analysis 
of tgPo brains to detect any possible prion replication would be of interest.
However, it was demonstrated that C-BSE prions can be present as a minor variant in ovine atypical scrapie 
isolates and that C-BSE can emerge during the passage of these isolates to bovine PrP  mice15. Considering that 
the aforementioned atypical scrapie isolate also acquired BSE-like properties when transmitted to tgPo  mice13, 
and that C-BSE is the only prion that efficiently propagates in swine  PrP4,7,14, we decided to investigate whether 
C-BSE prions could emerge from atypical scrapie during the ovine-porcine interspecies transmission.
Figure 1.  PrPres detected in PMCA reactions seeded with brain material (parietal cortex) from atypical scrapie 
inoculated pigs. Positive PMCA reactions show an identical glycoform pattern to that of cattle C-BSE prions 
and/or cattle C-BSE propagated in tgBov substrate (third line). Positive reactions were obtained from pigs 
inoculated with both original atypical scrapie isolates (PS152 isolate: P-1215 and P-1216; TOA3 isolate: P-1228). 
PMCA reactions seeded with brain homogenate from a TSE negative sheep and unseeded PMCA reactions 
are included as controls of the technique. PMCA reactions were subjected to 3 amplification rounds (15 s 
sonication, 14 min 50 s incubation at 39 °C) in a Qsonica700 sonicator and analyzed for  PrPres by western blot 
using the monoclonal anti-PrP antibodies Sha31 and 12B2. WB control = classical scrapie isolate.
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Interestingly, PMCA reactions seeded with brain material from 7 pigs propagated in tgBov substrate showing 
 PrPres with identical biochemical characteristics to those of C-BSE (Fig. 1). Positive C-BSE amplification was 
detected in the brain of pigs inoculated with either the PS152 or TOA3 atypical scrapie isolates, at minimum 
incubation periods of 28- and 35-months post inoculation, respectively. From each animal, positive reactions 
were not obtained from all brain areas tested (Supplementary table 1). Although  PrPres amplified from the pigs 
showed C-BSE biochemical characteristics, further bioassays in tgBov mice are required to know whether these 
prions replicate the neuropathological features of C-BSE.
Altogether, our results and data obtained from transmission studies of prions to pigs, tgPo mice and in vitro 
studies using porcine substrate have shown that pig PrP has a very limited ability to sustain prion replication. 
No significant polymorphisms have been described for pig PRNP22, and it has been suggested that the confor-
mational flexibility of pig PrP sequence is very low, limiting the number of  PrPSc conformations able to produce 
 misfolding14. No differences have been found between pig and minipig PrP sequences  either23, suggesting that 
the conclusions obtained here could be extrapolated to domestic, non-experimental pigs. However, using tgBov 
substrate, we have demonstrated in vitro the presence of C-BSE seeding activity in some pig brain areas, sug-
gesting that C-BSE prions emerged during the transmission of ovine atypical scrapie prions to pigs. Interestingly, 
C-BSE prions did not emerge from brain material of all the pigs, and, of those from which it did emerge, it was 
not detected in all brain areas tested. No correlation between time after inoculation and BSE emergence was 
found either. When the emergence of C-BSE from atypical scrapie in PMCA was described, it was associated 
to low levels of C-BSE prions that were present in the original atypical scrapie  isolates15. It is possible that this 
result is related to the great resistance that pigs present to prion diseases, making the penetrance of the BSE 
prions that could be present in the original inoculum incomplete. In addition, considering that the amount of 
C-BSE conformers in the atypical scrapie inocula is probably very reduced and perhaps not homogeneously 
distributed throughout the isolate, it is also possible that not all the pigs received a sufficient amount of C-BSE 
conformers capable of being detected by PMCA. Finally, we should consider that PMCA amplification of prions 
is sometimes a stochastic phenomenon, which could explain why no C-BSE propagation was obtained from some 
of the pigs. It could be also discussed that C-BSE emergence from the pig brains could be related to persistence 
of the original atypical scrapie inoculum. However, C-BSE amplification was not obtained from all of the pigs 
and, in some of them (i.e. P-1217 and P-1231) C-BSE propagation was detected in caudal regions of the brain 
(cerebellum or occipital cortex) but not in more rostral areas (such as parietal cortex). If C-BSE amplification 
from pig brain samples were associated to inoculum persistence and not bona fide propagation of C-BSE prions 
it would be expected that such amplification would be detected mainly in the most rostral areas of the brain. 
Finally, even though the titer generated was not enough to produce disease in the pigs, these results evidence 
again the issue that pigs could act as subclinical reservoirs for prion diseases as observed with scrapie and CWD, 
and that the presence of prions can be detected in pigs short after exposure to  prions7,10,11.
In conclusion, our findings suggest that, although pigs present a strong transmission barrier against the 
propagation of atypical scrapie, they can propagate low levels of C-BSE prions. The prevalence of atypical scra-
pie and the presence of infectivity in tissues from atypical scrapie infected sheep are  underestimated24,25. Given 
that pigs have demonstrated being susceptible to other prion diseases, and to propagate prions without showing 
signs of disease, the measures implemented to ban the inclusion of ruminant proteins in livestock feed must 
not be interrupted.
Material and methods
Ethics statement. All animal experiments were performed in strict accordance with the European Com-
munity Council Directive 2010/63/EU for the protection of animals used for experimental and other scientific 
purposes. Experimental procedures in pigs were approved by the Ethics Committee of the University of Zaragoza 
(Permit number: PI 13/10) and were carried out in strict accordance with the Spanish Policy on Animal Pro-
tection (RD 53/2013). The CISA-INIA Ethics Committee approved the experimental protocol in mice (Permit 
number: CEEA 2009/004). All experimental procedures in animals comply with the ARRIVE guidelines.
Atypical scrapie inocula. In the present study, two different atypical scrapie sources were used: PS152 
isolate and TOA3 isolate.
PS152 isolate (French isolate) was derived from the brain of an AfRQ/AfRQ clinical sheep naturally affected 
by atypical scrapie. This isolate was provided by UMR INRA ENVT 1225, Interactions Hôtes Agents Pathogènes, 
École Nationale Vétérinaire de Toulouse.
TOA3 isolate (Catalan isolate) was obtained from the brain of an AfRQ/AfRQ clinical sheep naturally affected 
by atypical scrapie and provided by the prion diseases research group of the IRTA-CReSA and Universitat 
Autònoma de Barcelona.
Experimental challenges in pigs. Twelve 9-month-old Sach miniature minipigs (11 females and 1 neu-
tered male) were intracerebrally inoculated under general anesthesia. Animals were purchased from the Centro 
de Transferencia Tecnológica “La Chimenea”, Aranjuez, Madrid, Spain, which is part of the Instituto Madrileño 
de Investigación y Desarrollo Rural, Agrario y Alimentario (IMIDRA). Pigs were housed together in the BSL3 
facility from Centro de Encefalopatías y Enfermedades Transmisibles Emergentes of the University of Zaragoza. 
The number of animals used was considered adequate to ensure both statistical significance and animal welfare 
in relation to housing. Females were selected mainly because they show better behavior and a lower tendency to 
aggression against other pigs.
Two groups of six animals were intracerebrally challenged with 0.5 ml of the PS152 isolate or the TOA3 isolate, 
respectively. Atypical scrapie inocula were prepared as 10% brain homogenate (w/v) in sterile saline solution. 
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Each animal received 0.05 g of brain tissue under xylazine and ketamine anesthesia. The trephine was done using 
a dental drill. Inocula were administered using a 25G needle. Intracerebral injections were performed as previ-
ously described for prion transmission studies in  pigs4. Briefly, each pig was inoculated into the frontal cortex 
of the left cerebral hemisphere. Before inserting the trephine, a parasagittal skin incision of 2 cm was made over 
the inoculation point to expose the periosteum. The injection was performed 1 cm lateral to the midline in the 
frontal region equidistant from the lateral canthus of the eye and the base of the cranial border of the pinna. 
After the inoculation, the incision was sutured, and pigs received intramuscular (IM) antibiotic treatment (pro-
caine benzylpenicillin, 10 mg/kg) and flunixin (IM, 2.2 mg/kg) to achieve analgesia. Details of the bioassay are 
presented in the results section (Table 1).
After the intracerebral injection, pigs were monitored daily by animal husbandry staff. The possible appear-
ance of locomotor impairments was monitored three days per week. Veterinary clinical assessments were per-
formed monthly in order to detect any clinical sign compatible with a prion disease, which in this species include 
behavioral alterations, depression, hyperreaction to stimuli, abnormal positions of the head and ears, confusion 
and  ataxia7.
Necropsy and tissue sample collection. Animals were sacrificed by intravenous pentobarbital injection 
(DOLETHAL; 10 mg/kg) followed by exsanguination. Pigs were euthanized between 632- and 2154-days post-
inoculation without showing clinical signs of prion disease. Several pigs were euthanized due to the develop-
ment of conditions nonrelated to prion disease that compromised their welfare. Due to the great cost involved 
in maintaining these animals, the rest of the pigs were electively slaughtered when a minimum of two years had 
passed after inoculation.  PrPSc accumulation in the brain was evaluated after every necropsy. Elective euthana-
sia of the animals was carried out at similar post-inoculation times for both inoculation groups except for pig 
P-1216, which was euthanized a few months after P-1231 because the latter showed no presence of  PrPSc in the 
brain, and it was decided to postpone the euthanasia of the next animal.
Necropsies were conducted systematically, and tissue samples were collected from the central nervous system 
using sterile prion-free material and equipment.
All samples were collected in duplicate, one sample was fixed in 10% formalin for the histological analysis 
and the other sample was stored at − 80 °C for further biochemical assays.
Enzyme immunoassay (EIA) for the detection of  PrPSc. Collected tissues (300 mg per sample) were 
analyzed by a ligand-based enzyme immunoassay (IDEXX HerdChek® BSE-Scrapie Antigen Test, referred to as 
EIA) as previously  described7,26. EIA test was performed following the manufacturer´s instructions, using the 
conjugate indicated for cattle and applying a negative cut-off value of 0.14 absorbance units.
Frontal cortex and cerebellum were selected as areas for the possible detection of atypical scrapie prions.
Histopathology and immunohistochemistry. Tissue samples were fixed in formalin for 48 h and then 
embedded in paraffin. 4 µm-thick sections were cut using a microtome and mounted on glass slides. Some sec-
tions were stained with hematoxylin and eosin for the histopathological study.  PrPSc detection was performed by 
immunohistochemistry using the monoclonal primary antibody 2G11 (1:400; Bertin Bioreagent) as previously 
 described7,27.
Mouse bioassay. PoPrP-Tg001 mouse line (tgPo)  was used in the bioassay experiments. This mouse 
line expresses the porcine  PrPC (around fourfold the level of expression in pig brain) under the control of the 
mouse prnp gene promoter in a mouse  PrP0/0  background19. Bioassays were performed as reported previously 
in experimental procedures from our  group28. Briefly, all inocula were prepared from brain tissues as 10% (w/v) 
homogenates in 5% glucose. Individually identified 6–10 week-old mice were anesthetized with isoflurane and 
inoculated with 2 mg of brain homogenate in the right parietal lobe using a 25-gauge disposable hypodermic 
needle. Mice were observed daily, and the neurological status was assessed weekly. When mice became too aged 
(> 650 dpi), animals were euthanized because of ethical reasons. Once euthanized, necropsy was performed, and 
the brain was collected. A part of the brain was fixed by immersion in 10% formalin to quantify spongiform 
degeneration by histopathology and proteinase K (PK) resistant PrP accumulation  (PrPres) by immunohisto-
chemistry (IHC) or histoblotting and the other part was frozen at − 20 °C to determine the presence of  PrPres by 
western blot.
PMCA amplification. Brains from transgenic mice overexpressing bovine PrP (tgBov)29 were used to pre-
pare the PMCA substrate (10% wt/vol in PMCA conversion buffer) which was supplemented with 0.25% wt/vol 
of low molecular weight dextran. The PMCA technique was carried out similarly to that previously described. 
PMCA reactions (50 μl final volume) were performed in 96 well microplates and subjected to 3 amplification 
rounds (15 s sonication, 14 min 50 s incubation at 39 °C) in a Qsonica700 sonicator. These conditions ensure a 
positive amplification of  10–9 diluted reference C-BSE isolate. After each round, reaction products were diluted 
1/10 in fresh substrate and subjected to a new PMCA round. Pig brain regions for PMCA amplification were 
selected according to the distribution of neuropathological lesions reported in pigs inoculated with C-BSE and 
sheep  BSE7,21. In these animals, most severe lesions are described in areas such as cerebral and cerebellar cortices, 
white matter structures and midbrain. Frontal cortex was not subjected to PMCA since pigs were inoculated in 
this brain area and a certain level of inoculum persistence could result in positive amplification by an ultrasensi-
tive technique such as  PMCA30.
Each pig brain area was tested in quadruplicate and the PMCA reaction products were blindly analyzed by 
western blot for the presence of  PrPres. In order to detect any possible cross contamination that could lead to a 
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false positive result, unseeded controls were placed in the microplate every 8 seeded wells and the complete plate 
was discarded when non-specific amplification was detected. In case of positive amplification, 12 replicates of the 
sample were retested under the same conditions. When all brain areas from an animal were negative for PMCA 
amplification, one selected brain area was retested in 12 replicates to confirm the negative result.
Western blotting. Biochemical analysis of  PrPres from PMCA products was performed by western blotting 
as previously  described15. Fresh samples were treated with PK (50 μg/ml), subjected to electrophoresis and blot-
ted onto membranes using the Prionics AG Check® Western BSE test protocol. Immunodetection was performed 
using Sha31 (1 µg/ml)31 and 12B2 (4 µg/ml)32 monoclonal antibodies.
Data availability
Data available within the article and its supplementary materials.
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